跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LH-1
首页
药物
LH-1
LH-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
US 7375109 B2
申请人: ORGANON NV
优先权: 2001
CN
US
3 件公开
Use of LH in controlled ovarian hyperstimulation
US 7341989 B2
申请人: LAB SERONOSA
优先权: 2001
CN
US
3 件公开
LHRH-antagonists in the treatment of fertility disorders
US 7393834 B2
申请人: AETERNA ZENTARIS GMBH
优先权: 2003
US
3 件公开
PROPANE- I-SULFONIC ACID {3- [5- (4 -CHLORO-PHENYL) -1H-PYRROLO [2, 3-B] PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENY L } -AMIDE COMPOSITIONS AND USES THEREOF
WO 2010114928 A3
申请人: HOFFMANN LA ROCHE
优先权: 2009
CN
WO
2 件公开
PHARMACEUTICAL FORMULATIONS OF BRUTON'S TYROSINE KINASE INHIBTOR
WO 2016141068 A1
申请人: PHARMACYCLICS LLC
优先权: 2015
CN
WO
2 件公开
CHOLINE SALT FORMS OF AN HIV CAPSID INHIBITOR
WO 2019035973 A1
申请人: GILEAD SCIENCES INC
优先权: 2017
CN
WO
2 件公开
2,3-DIHYDRO-1H-PYRROLO[3,4-C]PYRIDIN-1-ONE DERIVATIVES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER
WO 2020100027 A1
申请人: PFIZER
优先权: 2018
CN
WO
2 件公开
METHOD FOR PREPARING LH-1801 KEY INTERMEDIATE
WO 2026056066 A1
申请人: YANGZHOU PRINCECHEM CO LTD
优先权: 2024
CN
WO
2 件公开
GASTRORETENTIVE DOUBLE-LAYER SUSTAINED-RELEASE TABLET, PREPARATION METHOD THEREFOR, AND USE THEREOF
WO 2026137698 A1
申请人: ORXES THERAPEUTICS CO LTD
优先权: 2024
CN
WO
2 件公开
Metal complex, light-emitting device and display
US 7893611 B2
申请人: UNIV NAGASAKI
优先权: 2006
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈